Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.

about

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.

Item

http://www.wikidata.org/entity/Q52681038

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Impact of timing of adjuvant c ...... cer: a population-based study.

@en

Impact of timing of adjuvant c ...... cer: a population-based study.

@nl

type

Item

label

Impact of timing of adjuvant c ...... cer: a population-based study.

@en

Impact of timing of adjuvant c ...... cer: a population-based study.

@nl

prefLabel

Impact of timing of adjuvant c ...... cer: a population-based study.

@en

Impact of timing of adjuvant c ...... cer: a population-based study.

@nl

P1476

Impact of timing of adjuvant c ...... cer: a population-based study.

@en

P2093

Jing-Xu Sun

http://www.w3.org/2001/XMLSchema#string

Peng Gao

http://www.w3.org/2001/XMLSchema#string

Xiao-Wan Chen

http://www.w3.org/2001/XMLSchema#string

Xuan-Zhang Huang

http://www.w3.org/2001/XMLSchema#string

Yong-Xi Song

http://www.w3.org/2001/XMLSchema#string

Yu Sun

http://www.w3.org/2001/XMLSchema#string

Yu-Meng Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer

The impact of delayed chemotherapy on its completion and survival outcomes in stage II colon cancer patients.

Using diagnoses to describe populations and predict costs.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis.

Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

P2888

s12885-018-4138-7

P304

234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4138-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhenning Wang

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101279224

http://www.w3.org/2001/XMLSchema#string

P698

29490625

http://www.w3.org/2001/XMLSchema#string

P932

5831576

http://www.w3.org/2001/XMLSchema#string